Cyclosporine Ophthalmic Suspension [Restasis]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
PurposeCyclosporine A (Cs) has been used as effective topical therapy for inflammatory dry eye disease since more than a decade…
Zusammenfassung Hintergrund Alterung ist ein wichtiger, bislang in Bezug auf therapeutische Maßnahmen jedoch nur unzureichend ber…
Restasis® is the only ophthalmic medication containing cyclosporine A that is registered in the Russian Federation. According to…
The purpose of the study was to evaluate the efficacy and acceptability of the drug Restasis® in treatment of atopic…
A lot of researches have investigated the effects of topical cyclosporine A on the eye surface layers’ diseases. By now the main…
PURPOSE
This retrospective, clinical comparative analysis describes differences in clinical signs and symptoms and medication…
Purpose: We conducted a study to evaluate the change of tear secretion and symptoms in the patients with dry eye syndrome after…